227 related articles for article (PubMed ID: 31579886)
21. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
22. mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.
Zeng H; Cohen S; Guy C; Shrestha S; Neale G; Brown SA; Cloer C; Kishton RJ; Gao X; Youngblood B; Do M; Li MO; Locasale JW; Rathmell JC; Chi H
Immunity; 2016 Sep; 45(3):540-554. PubMed ID: 27637146
[TBL] [Abstract][Full Text] [Related]
23. IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma.
Pandey S; Mourcin F; Marchand T; Nayar S; Guirriec M; Pangault C; Monvoisin C; Amé-Thomas P; Guilloton F; Dulong J; Coles M; Fest T; Mottok A; Barone F; Tarte K
Blood; 2017 May; 129(18):2507-2518. PubMed ID: 28202459
[TBL] [Abstract][Full Text] [Related]
24. The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells.
Xu L; Huang Q; Wang H; Hao Y; Bai Q; Hu J; Li Y; Wang P; Chen X; He R; Li B; Yang X; Zhao T; Zhang Y; Wang Y; Ou J; Liang H; Wu Y; Zhou X; Ye L
Immunity; 2017 Sep; 47(3):538-551.e5. PubMed ID: 28930662
[TBL] [Abstract][Full Text] [Related]
25. EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma.
Julia E; Salles G
Future Oncol; 2021 Jun; 17(17):2127-2140. PubMed ID: 33709777
[TBL] [Abstract][Full Text] [Related]
26. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
27. Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells.
Essig K; Hu D; Guimaraes JC; Alterauge D; Edelmann S; Raj T; Kranich J; Behrens G; Heiseke A; Floess S; Klein J; Maiser A; Marschall S; Hrabĕ de Angelis M; Leonhardt H; Calkhoven CF; Noessner E; Brocker T; Huehn J; Krug AB; Zavolan M; Baumjohann D; Heissmeyer V
Immunity; 2017 Dec; 47(6):1067-1082.e12. PubMed ID: 29246441
[TBL] [Abstract][Full Text] [Related]
28. Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR.
Wang F; Gatica D; Ying ZX; Peterson LF; Kim P; Bernard D; Saiya-Cork K; Wang S; Kaminski MS; Chang AE; Phillips T; Klionsky DJ; Malek SN
J Clin Invest; 2019 Mar; 129(4):1626-1640. PubMed ID: 30720463
[TBL] [Abstract][Full Text] [Related]
29. Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion.
Martin TD; Chen XW; Kaplan RE; Saltiel AR; Walker CL; Reiner DJ; Der CJ
Mol Cell; 2014 Jan; 53(2):209-20. PubMed ID: 24389102
[TBL] [Abstract][Full Text] [Related]
30. Nutrient regulation of mTORC1 at a glance.
Condon KJ; Sabatini DM
J Cell Sci; 2019 Nov; 132(21):. PubMed ID: 31722960
[TBL] [Abstract][Full Text] [Related]
31. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
[TBL] [Abstract][Full Text] [Related]
32. T follicular helper cells in germinal center B cell selection and lymphomagenesis.
Mintz MA; Cyster JG
Immunol Rev; 2020 Jul; 296(1):48-61. PubMed ID: 32412663
[TBL] [Abstract][Full Text] [Related]
33. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
[TBL] [Abstract][Full Text] [Related]
34. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
Pangault C; Amé-Thomas P; Ruminy P; Rossille D; Caron G; Baia M; De Vos J; Roussel M; Monvoisin C; Lamy T; Tilly H; Gaulard P; Tarte K; Fest T
Leukemia; 2010 Dec; 24(12):2080-9. PubMed ID: 20944673
[TBL] [Abstract][Full Text] [Related]
35. Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.
Shortt J; Martin BP; Newbold A; Hannan KM; Devlin JR; Baker AJ; Ralli R; Cullinane C; Schmitt CA; Reimann M; Hall MN; Wall M; Hannan RD; Pearson RB; McArthur GA; Johnstone RW
Blood; 2013 Apr; 121(15):2964-74. PubMed ID: 23403624
[TBL] [Abstract][Full Text] [Related]
36. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
Murga-Zamalloa C; Rolland DCM; Polk A; Wolfe A; Dewar H; Chowdhury P; Onder O; Dewar R; Brown NA; Bailey NG; Inamdar K; Lim MS; Elenitoba-Johnson KSJ; Wilcox RA
Clin Cancer Res; 2020 Feb; 26(3):690-703. PubMed ID: 31636099
[TBL] [Abstract][Full Text] [Related]
37. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
38. Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation.
Gigoux M; Lovato A; Leconte J; Leung J; Sonenberg N; Suh WK
Mol Immunol; 2014 May; 59(1):46-54. PubMed ID: 24486724
[TBL] [Abstract][Full Text] [Related]
39. Cytoskeletal vimentin regulates cell size and autophagy through mTORC1 signaling.
Mohanasundaram P; Coelho-Rato LS; Modi MK; Urbanska M; Lautenschläger F; Cheng F; Eriksson JE
PLoS Biol; 2022 Sep; 20(9):e3001737. PubMed ID: 36099296
[TBL] [Abstract][Full Text] [Related]
40. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
